Hemorrhagic shock
Shock caused by massive blood loss is called hemorrhagic shock, which is common in bleeding caused by trauma, peptic ulcer bleeding, esophageal varicose vein rupture, and bleeding caused by gynecological diseases. Whether shock occurs after blood loss depends not only on the amount of blood loss, but also on the speed of blood loss. Shock often occurs when blood is lost quickly and in large quantities (more than 30-35% of the total blood volume) without timely replenishment.
-
Site of disease:
Blood vessels whole body -
Infectious :
Not contagious -
Frequent population:
No special disease group -
Related symptoms:
Blood appears concentrated Pulmonary artery wedge pressure (PCWP) is reduced Peripheral venous congestion Serum sodium is increased Skin is pale -
Concurrent disease:
Related Drugs
Hydroxyethyl starch 200/0.5 sodium chloride injection
Indication: Volume replacement therapy for the treatment and prevention of insufficient circulating blood volume or shock associated with the following conditions: 1. Surgery, hemorrhagic shock. 2. Trauma, traumatic shock. 3. Infection, septic shock. 4. Burns, burn shock. 5. Reduction of blood supply requirements during surgery: for example, acute isovolumetric hemodilution ANH. 6. Therapeutic hemodilution.
Hydroxyethyl starch 200/0.5 sodium chloride injection
Indication: Volume replacement therapy for the treatment and prevention of insufficient circulating blood volume or shock associated with the following conditions: 1. Surgery, hemorrhagic shock. 2. Trauma, traumatic shock. 3. Infection, septic shock. 4. Burns, burn shock. 5. Reduction of blood supply requirements during surgery: for example, acute isovolumetric hemodilution ANH. 6. Therapeutic hemodilution.
Hydroxyethyl starch 200/0.5 sodium chloride injection
Indication: Volume replacement therapy for the treatment and prevention of insufficient circulating blood volume or shock associated with the following conditions: 1. Surgery, hemorrhagic shock. 2. Trauma, traumatic shock. 3. Infection, septic shock. 4. Burns, burn shock. 5. Reduction of blood supply requirements during surgery: for example, acute isovolumetric hemodilution ANH. 6. Therapeutic hemodilution.
Hydroxyethyl starch 200/0.5 sodium chloride injection
Indication: Volume replacement therapy for the treatment and prevention of insufficient circulating blood volume or shock associated with the following conditions: 1. Surgery, hemorrhagic shock. 2. Trauma, traumatic shock. 3. Infection, septic shock. 4. Burns, burn shock. 5. Reduction of blood supply requirements during surgery: for example, acute isovolumetric hemodilution ANH. 6. Therapeutic hemodilution.
Hydroxyethyl starch 200/0.5 sodium chloride injection
Indication: Volume replacement therapy for the treatment and prevention of insufficient circulating blood volume or shock associated with the following conditions: 1. Surgery, hemorrhagic shock. 2. Trauma, traumatic shock. 3. Infection, septic shock. 4. Burns, burn shock. 5. Reduction of blood supply requirements during surgery: for example, acute isovolumetric hemodilution ANH. 6. Therapeutic hemodilution.
Coenzyme Q10 Injection
Indication: This product can be used as an auxiliary treatment drug for congestive heart failure, coronary heart disease, hypertension, arrhythmia, primary and secondary aldosteronism, sequelae of neck trauma, cerebrovascular disorder, hemorrhagic shock and hepatitis, etc.
Manufacturer:
Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.
Human serum albumin
Indication: 1. Prevention and treatment of decreased circulating blood volume. 2. Emergency treatment of shock: such as hemorrhagic shock, infectious toxic shock, etc. 3. Used for early and late treatment of burns. 4. Treatment of hypoproteinemia and edema: such as hypoproteinemia caused by cirrhosis, hepatitis B, nephrotic syndrome, chronic nutritional deficiencies caused by esophageal, gastric, and intestinal diseases, postoperative nutritional therapy, and cerebral edema, etc.
Manufacturer:
Chengdu Rongsheng Pharmaceuticals Co., Ltd.
Human serum albumin
Indication: 1. Prevention and treatment of decreased circulating blood volume. 2. Emergency treatment of shock: such as hemorrhagic shock, infectious toxic shock, etc. 3. Used for early and late treatment of burns. 4. Treatment of hypoproteinemia and edema: such as hypoproteinemia caused by cirrhosis, hepatitis B, nephrotic syndrome, chronic nutritional deficiencies caused by esophageal, gastric, and intestinal diseases, postoperative nutritional therapy, and cerebral edema, etc.
Manufacturer:
Chengdu Rongsheng Pharmaceuticals Co., Ltd.
Human serum albumin
Indication: 1. Prevention and treatment of decreased circulating blood volume. 2. Emergency treatment of shock: such as hemorrhagic shock, infectious toxic shock, etc. 3. Used for early and late treatment of burns. 4. Treatment of hypoproteinemia and edema: such as hypoproteinemia caused by cirrhosis, hepatitis B, nephrotic syndrome, chronic nutritional deficiencies caused by esophageal, gastric, and intestinal diseases, postoperative nutritional therapy, and cerebral edema, etc.
Manufacturer:
Chengdu Rongsheng Pharmaceuticals Co., Ltd.
Human serum albumin
Indication: 1. Prevention and treatment of decreased circulating blood volume. 2. Emergency treatment of shock: such as hemorrhagic shock, infectious toxic shock, etc. 3. Used for early and late treatment of burns. 4. Treatment of hypoproteinemia and edema: such as hypoproteinemia caused by cirrhosis, hepatitis B, nephrotic syndrome, chronic nutritional deficiencies caused by esophageal, gastric, and intestinal diseases, postoperative nutritional therapy, and cerebral edema, etc.
Manufacturer:
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
Related Ingredients